To The Moon

$Grab Holdings(GRAB)$How do you create a taxi business with a 12 billion market cap? Well, you start with a 40 billion market cap and 9 billion in VC and IPO funds, then lose 200 million every month, until the money is gone.

$Bright Minds Biosciences Inc(DRUG)$Bright minds Biosciences Inc (DRUG) has just unveiled a new phase I drug known as BMB-101 for Dravet Syndrome..now is the time to buy. Let's take the opportunity to buy before all investors know the news.

9 NEW INSTITUTIONAL Investors Today AUG 25 th as per Fintel. One for Over 2 MILLION FFIE Shares.. 2 for Over 400,000 FFIE Shares. Joining These WEALTH Creating Investors..$$..??$Faraday Future Intelligent Electric Inc.(FFIE)$

$GameStop(GME)$ Can anyone count outGameStop(NYSE:GME) at this point? It usually only takes a faint whisper to send GME stock rising or falling.The stock continues to experience regular highs and lows depending on news related to the video game retailer. Over the past 52 weeks, the stock has been as high as $63.92 and as low as $19.40 per share. And that price factors in a 4-for-1 stock split that took place on July 21.While analysts continue to write off GME stock and have anaverage targeton the shares of $17.50, representing 46% downside from the current share price of $31.66, many retail investors remain faithful to the original meme stock.GME stock fell most recently,declining in sympathywith BBBY stock. The fact that Cohen is the chairman of Game

$Bed Bath & Beyond(BBBY)$If BBBY could make some money, it would be worth far more than its present $1.1 billion. It did $7.3 billion in business last year. Even its “disastrous” May quarter saw revenue of$1.46 billion.The trouble is it lost $358 million, or $4.49 per share, on those May quarter sales, leading to reportssuppliers might halt product shipments. A newloan deal eased those worries, but only temporarily.The retailer’s earlier plans, based on private labels and a more “curated” selection under former CEO Mark Tritton, have been abandoned. But how will BBBY raise cash, bring shoppers back, and solve itssupply chain woes?  Will it sell Buy Buy Baby, a successful baby products chain Cohenwanted it to dump? Buy Buy Baby may not b

$Snowflake(SNOW)$Despite the market and economic upheaval this year, Snowflake has managed to continuegrowing its customer base.It also announced that its customers increased their spending on its products and services by 74% in the first quarter from a year earlier, which is a very high rate among cloud computing firms.When the company reports second-quarter results on Aug. 24, analysts expect the (still unprofitable) company to announce an earnings per share loss of two cents on revenues of $467 million.

$AMC Entertainment(AMC)$While the box office has recovered this summer and reports about the death of movie theaters appear to be premature, shares ofAMC Entertainment(NYSE:AMC), the largest movie theater chain in the world, continue to astound and confound.AMC stock most recently cratered, falling 63% since August 11 to $9.42 a share after the company announced plans to issue 517 million preferred shares, called “AMC Preferred Equity.”The new stocktrades under the ticker symbol “APE,”which is a nod to the retail investors that drove AMC stock higher during the pandemic. The new class of shares began trading on Aug. 22 and has the same voting rights as existing common shares.

Disappointing preliminary quarterly results pushedNvidia(NVDA) stock lower earlier this month. However, shares in the chip maker have since made up their recent losses. While facing challenges, as the company's long-term prospects remain solid, the market wasn't wrong in "buying the dip." So far in August,Nvidia(NASDAQ:NVDA) stock has been making some whipsaw moves. Following its announcement of preliminary results for the preceding quarter, investors bailed out of the chip maker’s shares, sending the stock lower by double-digits over two trading days.But not too long after that, the stock bounced back to levels seen just before the preliminary earnings news. At first glance, you may think this is an odd move for shares to make. After all, the latest results suggest more challenges lie ahe

MindMed(MNMD) briefly doubled overnight on rumors of a short squeeze. The company is testing LSD to treat symptoms of ADHD, anxiety and other conditions. The drug is still in its Phase 2 study and a long way from the market. Source: ShutterstockPenny stockMind Medicine(NASDAQ:MNMD) stock nearly doubled overnight on rumors of a short squeeze.Shares that opened at 68 cents early on Aug. 17 were trading at $1.16 before the market opened on Aug. 18, after trading as high as $1.40 earlier in the morning.The move comes as the company prepares for a1-for-15 reverse stock split. After the split, there will be 28.4 million shares outstanding.MNMD Stock: Behind the NewsMindMedis researching the use of psychedelics for treatment of anxiety, pain, substance abuse and autism. It has a pipeline of drug

$Palantir Technologies Inc.(PLTR)$Palantirblamed the earnings misson a decline in investments and marketable securities. In terms of revenue, Palantir reported $473 million for the quarter. This was slightly better than the $471.3 million expected by analysts who cover the company. Overall, revenue was up 26% from a year earlier, helped by a 46% increase in the company’s commercial revenue.Palantir, which markets itself as a software company, said its number of private sector and commercial customers grew 250% from a year earlier, rising to 119 from 34 in the same period of 2021.Looking ahead, the company said it expects to report revenue between $474 million and $475 million for the current third quarter, and between $1.9 billion and $1.902 bil